Amendment passes that will create greater transparency in drug safety advisory panels
September 28, 2005
Currently, the public has to file a freedom of information request to get the names of the companies involved and the amounts paid to those scientists for consulting, speaking, doing studies and the like. Anyone who has ever filed a FOIA request with FDA (or most other agencies in this administration) knows that the process can take years.
There is one final element to the Senate bill. The FDA will have to document its efforts to find unconflicted scientists every time they create a new advisory panel. While this in itself doesn’t change anything, it creates an incentive for the agency to at least try to find unconflicted scientists since the alternative is to file blank reports.